Yanbei Tu

981 total citations · 1 hit paper
42 papers, 732 citations indexed

About

Yanbei Tu is a scholar working on Molecular Biology, Pharmacology and Plant Science. According to data from OpenAlex, Yanbei Tu has authored 42 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Pharmacology and 11 papers in Plant Science. Recurrent topics in Yanbei Tu's work include Natural product bioactivities and synthesis (12 papers), Phytochemistry and Biological Activities (7 papers) and Biological and pharmacological studies of plants (6 papers). Yanbei Tu is often cited by papers focused on Natural product bioactivities and synthesis (12 papers), Phytochemistry and Biological Activities (7 papers) and Biological and pharmacological studies of plants (6 papers). Yanbei Tu collaborates with scholars based in China, Macao and Hong Kong. Yanbei Tu's co-authors include Yanfang Li, Chengwei He, Lihua Tan, Kai Wang, Hanqing Liu, Xuejing Jia, Chao Zhu, Jian‐Bo Wan, Ying Yang and Wei Luo and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and Molecules.

In The Last Decade

Yanbei Tu

37 papers receiving 724 citations

Hit Papers

CETSA and thermal proteome profiling strategies for targe... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanbei Tu China 17 364 166 135 126 85 42 732
Chun-Feng Zhang China 16 363 1.0× 106 0.6× 142 1.1× 134 1.1× 79 0.9× 30 720
Jinhua Tao China 18 488 1.3× 112 0.7× 177 1.3× 134 1.1× 177 2.1× 42 879
Baoqin Lin China 17 320 0.9× 87 0.5× 122 0.9× 108 0.9× 123 1.4× 31 676
Zhaoqing Meng China 15 311 0.9× 68 0.4× 147 1.1× 159 1.3× 114 1.3× 68 675
Anagha Damre India 15 265 0.7× 64 0.4× 161 1.2× 146 1.2× 115 1.4× 30 673
Pengtao You China 16 356 1.0× 77 0.5× 96 0.7× 122 1.0× 76 0.9× 46 823
Peng An China 15 308 0.8× 113 0.7× 91 0.7× 63 0.5× 68 0.8× 33 727
Jiasi Wu China 14 292 0.8× 167 1.0× 100 0.7× 126 1.0× 80 0.9× 17 599
Jun Yeon Park South Korea 19 505 1.4× 135 0.8× 170 1.3× 175 1.4× 113 1.3× 53 907

Countries citing papers authored by Yanbei Tu

Since Specialization
Citations

This map shows the geographic impact of Yanbei Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbei Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbei Tu more than expected).

Fields of papers citing papers by Yanbei Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanbei Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbei Tu. The network helps show where Yanbei Tu may publish in the future.

Co-authorship network of co-authors of Yanbei Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanbei Tu. A scholar is included among the top collaborators of Yanbei Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanbei Tu. Yanbei Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Zhiquan, et al.. (2025). Targeting CD30L in B-cell non-Hodgkin lymphoma: novel peptide conjugates and their therapeutic potential. Molecular Cancer. 24(1). 189–189.
2.
Wang, Na, Qin Yin, H. Eric Xu, et al.. (2025). Shi Wei Ru Xiang pill alleviates acute gouty arthritis through suppressing NLRP3 inflammasome activation. Frontiers in Pharmacology. 16. 1595578–1595578.
3.
Li, Lin, et al.. (2025). A naturally occurring phenanthrene from Pleione bulbocodioides inhibits osteoclast formation by directly targeting Src kinase. European Journal of Pharmacology. 1002. 177854–177854.
8.
Tan, Lihua, Yuxin Zhao, Yanping Liang, et al.. (2024). Dual regulation of phaseol on osteoclast formation and osteoblast differentiation by targeting TAK1 kinase for osteoporosis treatment. Journal of Advanced Research. 76. 761–779. 3 indexed citations
9.
Tu, Yanbei, et al.. (2023). CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products. Phytomedicine. 116. 154862–154862. 97 indexed citations breakdown →
11.
Hua, Peng, et al.. (2023). Reactive oxygen species and nitric oxide scavenging nanoparticles alleviating rheumatoid arthritis through adjusting the seeds and growing soils. Acta Pharmaceutica Sinica B. 13(12). 5016–5029. 15 indexed citations
12.
Zhong, Ruting, Lingchao Miao, Haolin Zhang, et al.. (2022). Anti-inflammatory activity of flavonols via inhibiting MAPK and NF-κB signaling pathways in RAW264.7 macrophages. Current Research in Food Science. 5. 1176–1184. 46 indexed citations
14.
Liu, Yi, Yanbei Tu, Tao Wang, et al.. (2022). Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction. Bioorganic Chemistry. 131. 106320–106320. 20 indexed citations
15.
Liu, Yan, et al.. (2021). Investigation of the interaction between Chrysoeriol and xanthine oxidase using computational and in vitro approaches. International Journal of Biological Macromolecules. 190. 463–473. 37 indexed citations
18.
Jia, Xuejing, Chao Zhang, Jiaolin Bao, et al.. (2019). Flavonoids from Rhynchosia minima root exerts anti-inflammatory activity in lipopolysaccharide-stimulated RAW 264.7 cells via MAPK/NF-κB signaling pathway. Inflammopharmacology. 28(1). 289–297. 16 indexed citations
19.
Tu, Yanbei, et al.. (2019). Highly selective carbamate-based butyrylcholinesterase inhibitors derived from a naturally occurring pyranoisoflavone. Bioorganic Chemistry. 88. 102949–102949. 20 indexed citations
20.
Jia, Xuejing, Yeer Liang, Chao Zhang, et al.. (2018). Polysaccharide PRM3 from Rhynchosia minima root enhances immune function through TLR4-NF-κB pathway. Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(8). 1751–1759. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026